Company news
Hybio Pharmaceutical Co., Ltd. Class A (SZSE:300199) news
Hybio Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Jul 6, 2026: Hybio Pharmaceutical Unit's Chemical API Liraglutide Approved By China's…
Press releases & updates
Hybio Pharmaceutical Unit's Chemical API Liraglutide Approved By China's Regulator
July 6, 2026
Hybio Pharmaceutical's Liraglutide Injection Approved By China's National Medical Products Administration
July 1, 2026
Hybio's generic weight-loss drug set for FDA review
June 30, 2026
Hybio Pharmaceutical Plans To Raise Fund Via Share Private Placement
September 25, 2025